{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:38:26Z","timestamp":1792003106922,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cveq.2024.10.002","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:13:07Z","timestamp":1738080787000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetics of Muscle Disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Carrie J.","family":"Finno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cveq.2024.10.002_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0960-8966(06)80006-4","article-title":"Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses","volume":"2","author":"Valberg","year":"1992","journal-title":"Neuromuscul Dis"},{"key":"10.1016\/j.cveq.2024.10.002_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cveq.2020.03.012","article-title":"Genetics of equine muscle disease","volume":"36","author":"Valberg","year":"2020","journal-title":"Vet Clin N Amer Equine Pract"},{"key":"10.1016\/j.cveq.2024.10.002_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00335-004-2369-1","article-title":"Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV","volume":"15","author":"Ward","year":"2004","journal-title":"Mamm Genome"},{"key":"10.1016\/j.cveq.2024.10.002_bib4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2460\/javma.1990.197.08.1009","article-title":"Hyperkalemic periodic paralysis in horses","volume":"197","author":"Spier","year":"1990","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.10.002_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0749-0739(17)30260-2","article-title":"Hyperkalemic periodic paralysis","volume":"13","author":"Naylor","year":"1997","journal-title":"Vet Clin N Amer Equine Pract"},{"key":"10.1016\/j.cveq.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2460\/javma.1996.209.04.798","article-title":"Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis","volume":"209","author":"Carr","year":"1996","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.10.002_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2460\/javma.1994.204.06.926","article-title":"Selection of quarter horses affected with hyperkalemic periodic paralysis by show judges","volume":"204","author":"Naylor","year":"1994","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.10.002_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1092-144","article-title":"Periodic paralysis in quarter horses: a sodium channel mutation disseminated by selective breeding","volume":"2","author":"Rudolph","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.cveq.2024.10.002_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ygeno.2007.03.009","article-title":"Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse","volume":"90","author":"Tryon","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.cveq.2024.10.002_bib10","doi-asserted-by":"crossref","first-page":"104129","DOI":"10.1016\/j.jevs.2022.104129","article-title":"Prevalence of genetic mutations in horses with muscle disease from a neuromuscular disease laboratory","volume":"118","author":"Aleman","year":"2022","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2024.10.002_bib11","doi-asserted-by":"crossref","first-page":"105052","DOI":"10.1016\/j.jevs.2024.105052","article-title":"Allele frequency of muscular genetic disorders in bull-catching (vaquejada) quarter horses","volume":"136","author":"Sperandio","year":"2024","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2024.10.002_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/mus.20084","article-title":"Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia","volume":"30","author":"Aleman","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cveq.2024.10.002_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1939-1676.2009.0274.x","article-title":"Malignant hyperthermia associated with ryanodine receptor 1 (C7360G) mutation in Quarter Horses","volume":"23","author":"Aleman","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1939-1676.2005.tb02710.x","article-title":"Malignant hyperthermia in a horse anesthetized with halothane","volume":"19","author":"Aleman","year":"2005","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2460\/javma.1990.197.08.1051","article-title":"Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse","volume":"197","author":"Valverde","year":"1990","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.10.002_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1939-1676.2001.tb01593.x","article-title":"Glycogen branching enzyme deficiency in quarter horse foals","volume":"15","author":"Valberg","year":"2001","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1354\/vp.36-2-157","article-title":"Amylopectinosis in fetal and neonatal quarter horses","volume":"36","author":"Render","year":"1999","journal-title":"Vet Path"},{"key":"10.1016\/j.cveq.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1939-1676.2006.tb00724.x","article-title":"Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint horse populations","volume":"20","author":"Wagner","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2460\/ajvr.2003.64.1319","article-title":"Epidemiologic characteristics and management of polysaccharide storage myopathy in Quarter Horses","volume":"64","author":"Firshman","year":"2003","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.10.002_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.2042-3306.1997.tb01672.x","article-title":"Severe polysaccharide storage myopathy in Belgian and Percheron draught horses","volume":"29","author":"Valentine","year":"1997","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib21","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2460\/javma.2005.227.1958","article-title":"Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses","volume":"227","author":"Firshman","year":"2005","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/104063870101300112","article-title":"Incidence of polysaccharide storage myopathy in draft horse-related breeds: a necropsy study of 37 horses and a mule","volume":"13","author":"Valentine","year":"2001","journal-title":"J\u00a0Vet Diag Invest"},{"key":"10.1016\/j.cveq.2024.10.002_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2746\/042516402776767259","article-title":"Polysaccharide storage myopathy in the M. longissimus lumborum of showjumpers and dressage horses with back pain","volume":"34","author":"Quiroz-Rothe","year":"2002","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.2042-3306.2006.tb05565.x","article-title":"Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders","volume":"36","author":"McCue","year":"2006","journal-title":"Equine Vet J Suppl"},{"key":"10.1016\/j.cveq.2024.10.002_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2042-3306.1999.tb05279.x","article-title":"Exertional rhabdomyolysis in quarter horses and thoroughbreds: one syndrome, multiple aetiologies","volume":"30","author":"Valberg","year":"1999","journal-title":"Equine Vet J Suppl"},{"key":"10.1016\/j.cveq.2024.10.002_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygeno.2008.01.011","article-title":"Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis","volume":"91","author":"McCue","year":"2008","journal-title":"Genomics"},{"issue":"Suppl 2","key":"10.1016\/j.cveq.2024.10.002_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2052.2010.02124.x","article-title":"Estimated prevalence of the type 1 polysaccharide storage myopathy mutation in selected North American and European breeds","volume":"41","author":"McCue","year":"2010","journal-title":"Anim Genet"},{"key":"10.1016\/j.cveq.2024.10.002_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/vr.c3447","article-title":"Presence of the glycogen synthase 1 (GYS1) mutation causing type 1 polysaccharide storage myopathy in continental European draught horse breeds","volume":"167","author":"Baird","year":"2010","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2024.10.002_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tvjl.2016.08.011","article-title":"Clinical, histopathological and metabolic responses following exercise in Arabian horses with a history of exertional rhabdomyolysis","volume":"216","author":"McKenzie","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13395-018-0155-0","article-title":"A\u00a0missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses","volume":"8","author":"Finno","year":"2018","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.cveq.2024.10.002_bib31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/jvim.15299","article-title":"An E321G MYH1 mutation is strongly associated with nonexertional rhabdomyolysis in Quarter Horses","volume":"32","author":"Valberg","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib32","first-page":"495","article-title":"Suspected immune-mediated myositis in horses","volume":"21","author":"Lewis","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jvim.14637","article-title":"Clinical implications and hospital outcome of immune-mediated myositis in horses","volume":"31","author":"Hunyadi","year":"2017","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib34","first-page":"993","article-title":"Suspected systemic calcinosis and calciphylaxis in 5 horses","volume":"51","author":"Tan","year":"2010","journal-title":"Can Vet J"},{"issue":"12","key":"10.1016\/j.cveq.2024.10.002_bib35","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.3390\/cells10123428","article-title":"Myofibre hyper-contractility in horses expressing the myosin heavy chain myopathy mutation, MYH1(E321G)","volume":"10","author":"Ochala","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cveq.2024.10.002_bib36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jvim.16417","article-title":"Prevalence of clinical signs and factors impacting expression of myosin heavy chain myopathy in Quarter Horse-related breeds with the MYH1(E321G) mutation","volume":"36","author":"Valberg","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvim.15393","article-title":"Prevalence of the E321G MYH1 variant for immune-mediated myositis and nonexertional rhabdomyolysis in performance subgroups of American Quarter Horses","volume":"33","author":"Gianino","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.10.002_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1354\/vp.08-VP-0177-M-FL","article-title":"Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses","volume":"46","author":"McCue","year":"2009","journal-title":"Vet Path"},{"key":"10.1016\/j.cveq.2024.10.002_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2460\/ajvr.78.11.1305","article-title":"Clinical characteristics and muscle glycogen concentrations in warmblood horses with polysaccharide storage myopathy","volume":"78","author":"Lewis","year":"2017","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.10.002_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/evj.12493","article-title":"Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis","volume":"48","author":"Valberg","year":"2016","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/evj.12702","article-title":"Clinical and histopathological features of myofibrillar myopathy in Warmblood horses","volume":"49","author":"Valberg","year":"2017","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s13353-018-0463-4","article-title":"Myofibrillar myopathy in the genomic context","volume":"59","author":"Fichna","year":"2018","journal-title":"J\u00a0Appl Genet"},{"key":"10.1016\/j.cveq.2024.10.002_bib43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/evj.13345","article-title":"Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis","volume":"53","author":"Valberg","year":"2021","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/evj.13574","article-title":"Absence of myofibrillar myopathy in Quarter Horses with a histopathological diagnosis of type 2 polysaccharide storage myopathy and lack of association with commercial genetic tests","volume":"55","author":"Valberg","year":"2023","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/evj.13876","article-title":"Type 2 polysaccharide storage myopathy in Quarter Horses is a novel glycogen storage disease causing exertional rhabdomyolysis","volume":"55","author":"Valberg","year":"2023","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib46","doi-asserted-by":"crossref","first-page":"e11594","DOI":"10.1371\/journal.pone.0011594","article-title":"Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance","volume":"5","author":"Isgren","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cveq.2024.10.002_bib47","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2460\/ajvr.1999.60.12.1562","article-title":"Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds","volume":"60","author":"MacLeay","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.10.002_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/vr.151.21.623","article-title":"Incidence and risk factors for exertional rhabdomyolysis in thoroughbred racehorses in the United Kingdom","volume":"151","author":"McGowan","year":"2002","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2024.10.002_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2746\/042516408X244262","article-title":"An epidemiological study of myopathies in Warmblood horses","volume":"40","author":"Hunt","year":"2008","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.2042-3306.1993.tb02894.x","article-title":"Blood chemistry and skeletal muscle metabolic responses to exercise in horses with recurrent exertional rhabdomyolysis","volume":"25","author":"Valberg","year":"1993","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.10.002_bib51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2460\/ajvr.1999.60.02.250","article-title":"Heritability of recurrent exertional rhabdomyolysis in Thoroughbred racehorses","volume":"60","author":"MacLeay","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.10.002_bib52","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2460\/javma.2005.227.762","article-title":"Inheritance of recurrent exertional rhabdomyolysis in thoroughbreds","volume":"227","author":"Dranchak","year":"2005","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.10.002_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jhered\/esw042","article-title":"Heritability of recurrent exertional rhabdomyolysis in standardbred and thoroughbred racehorses derived from SNP genotyping data","volume":"107","author":"Norton","year":"2016","journal-title":"J\u00a0Hered"},{"key":"10.1016\/j.cveq.2024.10.002_bib54","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2460\/ajvr.2002.63.1724","article-title":"Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis","volume":"63","author":"Lentz","year":"2002","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.10.002_bib55","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2460\/ajvr.67.8.1395","article-title":"Exclusion of linkage of the RYR1, CACNA1S, and ATP2A1 genes to recurrent exertional rhabdomyolysis in Thoroughbreds","volume":"67","author":"Dranchak","year":"2006","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2024.10.002_bib56","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/jvim.15425","article-title":"Coding sequences of sarcoplasmic reticulum calcium ATPase regulatory peptides and expression of calcium regulatory genes in recurrent exertional rhabdomyolysis","volume":"33","author":"Valberg","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"12","key":"10.1016\/j.cveq.2024.10.002_bib57","first-page":"289","article-title":"Sarcoplasmic reticulum from horse gluteal muscle is poised for enhanced calcium transport","volume":"8","author":"Autry","year":"2021","journal-title":"Vet Sci"},{"key":"10.1016\/j.cveq.2024.10.002_bib58","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2052.2012.02351.x","article-title":"Genetic mapping of recurrent exertional rhabdomyolysis in a population of North American Thoroughbreds","volume":"43","author":"Fritz","year":"2012","journal-title":"Anim Genet"},{"key":"10.1016\/j.cveq.2024.10.002_bib59","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3390\/genes13101853","article-title":"Enriched pathways of calcium regulation, cellular\/oxidative stress, inflammation, and cell proliferation characterize gluteal muscle of standardbred horses between episodes of recurrent exertional rhabdomyolysis","volume":"13","author":"Valberg","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.cveq.2024.10.002_bib60","doi-asserted-by":"crossref","first-page":"e0244556","DOI":"10.1371\/journal.pone.0244556","article-title":"Pathways of calcium regulation, electron transport, and mitochondrial protein translation are molecular signatures of susceptibility to recurrent exertional rhabdomyolysis in Thoroughbred racehorses","volume":"16","author":"Aldrich","year":"2021","journal-title":"PLoS One"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073924000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073924000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:40:41Z","timestamp":1762310441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073924000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0749073924000889"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2024.10.002","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Muscle Disease","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}